Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-727,298
Closed -$121M 88
2016
Q3
$121M Sell
727,298
-30,853
-4% -$5.22M 2.55% 21
2016
Q2
$115M Sell
758,151
-40,442
-5% -$6.29M 2.35% 21
2016
Q1
$120M Sell
798,593
-229,849
-22% -$34.1M 2.2% 26
2015
Q4
$167M Buy
1,028,442
+203,350
+25% +$32M 3.08% 14
2015
Q3
$114M Sell
825,092
-258,972
-24% -$40.8M 1.9% 28
2015
Q2
$166M Sell
1,084,064
-252,603
-19% -$40.5M 2.37% 24
2015
Q1
$214M Sell
1,336,667
-88,001
-6% -$13.9M 2.59% 20
2014
Q4
$227M Buy
+1,424,668
New +$222M 2.49% 20

Other funds holding AMGN

Montag & Caldwell's AMGN Position: Q4 2016 in Review

Montag & Caldwell sold out of Amgen (AMGN) in Q4 2016, closing a stake of 727,298 shares — an estimated $121M sold.

Montag & Caldwell first reported a position in AMGN in Q4 2014 and held it in 8 quarters. The position peaked at $227M in Q4 2014. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Montag & Caldwell reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
  • Montag & Caldwell sold 727,298 Amgen shares in Q4 2016, an estimated $121M.
  • Montag & Caldwell first reported a position in Amgen in Q4 2014 and held it in 8 quarters.
  • Montag & Caldwell's Amgen position peaked at $227M in Q4 2014.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Montag & Caldwell's 13F filing for Q4 2016, filed 7 Feb 2017.